← FDA Drug Approvals (Drugs@FDA)
IRINOTECAN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2017-05-26
Drug application
- FDA Application #
ANDA206935- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IRINOTECAN HYDROCHLORIDE
- Generic name
- IRINOTECAN HYDROCHLORIDE
- Active ingredients
- IRINOTECAN HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- NOVAST LABS
- Manufacturer
- Ingenus Pharmaceuticals, LLC
- First approval
- 2017-05-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown